Cargando…
Vitamin D treatment attenuates 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced colitis but not oxazolone-induced colitis
Crohn’s disease (CD) and ulcerative colitis (UC) have different immunological mechanisms, while both of them are potential targets of vitamin D treatment. In this study, we have tried to address the role of vitamin D in CD and UC using two mouse models. Mice of C57B6L were given vitamin D before the...
Autores principales: | Liu, Tianjing, Shi, Yongyan, Du, Jie, Ge, Xin, Teng, Xu, Liu, Lu, Wang, Enbo, Zhao, Qun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020649/ https://www.ncbi.nlm.nih.gov/pubmed/27620138 http://dx.doi.org/10.1038/srep32889 |
Ejemplares similares
-
Effects of Humanin on Experimental Colitis Induced by 2,4,6-trinitrobenzene Sulphonic Acid in Rats
por: Gultekin, Fatma A., et al.
Publicado: (2017) -
Intestinal vitamin D receptor knockout protects from oxazolone-induced colitis
por: Shi, Yongyan, et al.
Publicado: (2020) -
Correction: Intestinal vitamin D receptor knockout protects from oxazolone-induced colitis
por: Shi, Yongyan, et al.
Publicado: (2020) -
Astragaloside IV ameliorates 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis implicating regulation of energy metabolism
por: Jiang, Xu-Guang, et al.
Publicado: (2017) -
A Chemically Induced Experimental Colitis Model with a Simple Combination of Acetic Acid and Trinitrobenzene Sulphonic Acid
por: Cinpolat, Havva Yasemin, et al.
Publicado: (2023)